|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Aptina_Imaging
|
|
gptkbp:audience
|
active communication channels
|
|
gptkbp:awards
|
Best Places to Work
|
|
gptkbp:business_model
|
B2 B and B2 C
|
|
gptkbp:ceo
|
gptkb:Christian_Henry
|
|
gptkbp:collaborations
|
various academic institutions
with leading universities
|
|
gptkbp:committee
|
composed of experts
|
|
gptkbp:community
|
active user forums
|
|
gptkbp:community_engagement
|
various outreach programs
|
|
gptkbp:community_involvement
|
educational initiatives
|
|
gptkbp:competitors
|
gptkb:Illumina
|
|
gptkbp:conference
|
annual user group meetings
|
|
gptkbp:cultural_representation
|
inclusive workplace policies
|
|
gptkbp:customer_base
|
academic and commercial entities
|
|
gptkbp:customer_support
|
dedicated support teams
|
|
gptkbp:developer
|
ongoing R& D
|
|
gptkbp:employees
|
over 500
|
|
gptkbp:feedback
|
positive reviews
|
|
gptkbp:financial_performance
|
growing revenue
|
|
gptkbp:focus_area
|
genomic research
|
|
gptkbp:founded
|
gptkb:2004
|
|
gptkbp:founder
|
gptkb:Harris_Wang
|
|
gptkbp:future_plans
|
expansion into new markets
|
|
gptkbp:global_presence
|
international customers
|
|
gptkbp:grants
|
various funding sources
|
|
gptkbp:headcount
|
approximately 600
|
|
gptkbp:headquarters
|
gptkb:Menlo_Park,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pacific Biosciences of California, Inc.
|
|
gptkbp:industry
|
genomics
|
|
gptkbp:innovation
|
continuous improvements
leading in sequencing technology
|
|
gptkbp:invention
|
over 200
strong IP portfolio
|
|
gptkbp:investment
|
gptkb:Soft_Bank
in R& D
|
|
gptkbp:key_people
|
Michael Hunkapiller
|
|
gptkbp:location
|
gptkb:California
|
|
gptkbp:market
|
to identify trends
new sequencing platforms
|
|
gptkbp:market_cap
|
$1 billion (2021)
|
|
gptkbp:marketing_strategy
|
focus on innovation
|
|
gptkbp:partnership
|
gptkb:Illumina
with tech companies
|
|
gptkbp:partnerships
|
pharmaceutical companies
for startups
|
|
gptkbp:population_trend
|
growing demand for sequencing
|
|
gptkbp:products
|
gptkb:Pac_Bio_Sequel_System
based on customer needs
|
|
gptkbp:publishes
|
numerous scientific papers
|
|
gptkbp:regulatory_compliance
|
FDA regulations
|
|
gptkbp:research_focus
|
single-molecule sequencing
|
|
gptkbp:revenue
|
$100 million (2020)
|
|
gptkbp:risk_factor
|
strategic planning
|
|
gptkbp:services
|
DNA sequencing
|
|
gptkbp:social_responsibility
|
commitment to ethics
|
|
gptkbp:strategic_importance
|
expansion in genomics market
|
|
gptkbp:subsidiary
|
Pacific Biosciences, Inc.
|
|
gptkbp:supply_chain
|
global suppliers
|
|
gptkbp:sustainability_initiatives
|
green practices
|
|
gptkbp:symbol
|
gptkb:PACB
|
|
gptkbp:technology
|
SMRT sequencing
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:training
|
for researchers
ongoing development programs
|
|
gptkbp:website
|
www.pacb.com
|
|
gptkbp:bfsParent
|
gptkb:PACB
|
|
gptkbp:bfsLayer
|
6
|